Sisaf Logo
  • Home
  • Company
  • Team
  • Pipeline
  • Technology
  • News
Show Menu
Menu

Archive: Year: 2020

 
SiSaf Ltd Announces US$13.2 Million Series B Financing
Read More
 
Non-invasive ocular siRNA delivery induces effective gene silencing in corneal epithelium
Read More
 
SiSaf announces licencing agreement to develop gene therapy for rare bone disease
Read More
 
SiSaf Makes Its Bio-CourierĀ® Technology Available for COVID-19 Vaccine Research
Read More

ARCHIVE

  • 2022 (2)
  • 2021 (2)
  • 2020 (4)
  • 2019 (3)
  • 2018 (2)
  • 2017 (1)
  • 2016 (1)
  • 2015 (1)
  • 2014 (1)
SiSaf Logo
BIA Logo

Contact SiSaf Ltd

+44 1483 912002 | info@sisaf.com

SiSaf © 2022

Terms and Conditions

Privacy Policy

FIND US

LONDON | BELFAST | DALLAS

Linkedin Icon

Cookies

This website uses cookies. By proceeding navigating on this page, you agree to the use of the cookies according to the terms of our Privacy Policy Find out more.